Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ViGenCell Inc. was founded in February 2013 as the first subsidiary company of the Catholic University Technology Holdings based on the clinically proven immune cell therapy technologies developed by the Catholic University of Korea. As a company founded on the idea of respect for life, we will make utmost efforts to create a sound profit model, pursue social contribution through the advancements in medical industry and play a...
ViGenCell Inc. was founded in February 2013 as the first subsidiary company of the Catholic University Technology Holdings based on the clinically proven immune cell therapy technologies developed by the Catholic University of Korea. As a company founded on the idea of respect for life, we will make utmost efforts to create a sound profit model, pursue social contribution through the advancements in medical industry and play a leading role in industrial-academic cooperation. Furthermore, we will reinforce our research capabilities & commercialize advanced technologies to grow into a successful global pharmaceutical company.

List your booth number for exhibitions, ask us